Wells Fargo’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,800
Closed -$963 7378
2024
Q4
$963 Hold
1,800
﹤0.01% 6260
2024
Q3
$3.17K Buy
+1,800
New +$2.51K ﹤0.01% 6001
2024
Q2
Sell
-16,374
Closed -$148K 7691
2024
Q1
$148K Buy
16,374
+2,430
+17% +$23.6K ﹤0.01% 4662
2023
Q4
$152K Buy
13,944
+3,273
+31% +$24.5K ﹤0.01% 4639
2023
Q3
$85.9K Sell
10,671
-10,096
-49% -$84K ﹤0.01% 4865
2023
Q2
$226K Buy
20,767
+20,455
+6,556% +$175K ﹤0.01% 4512
2023
Q1
$2.15K Buy
312
+16
+5% +$100 ﹤0.01% 6213
2022
Q4
$1.18K Buy
296
+71
+32% +$349 ﹤0.01% 6137
2022
Q3
$1K Buy
225
+4
+2% +$25 ﹤0.01% 6514
2022
Q2
$1K Sell
221
-4,647
-95% -$28.3K ﹤0.01% 6662
2022
Q1
$46K Sell
4,868
-13,191
-73% -$131K ﹤0.01% 5702
2021
Q4
$214K Buy
18,059
+17,858
+8,885% +$206K ﹤0.01% 5224
2021
Q3
$2K Hold
201
﹤0.01% 6609
2021
Q2
$3K Sell
201
-5,768
-97% -$92.8K ﹤0.01% 6489
2021
Q1
$92K Sell
5,969
-18,033
-75% -$261K ﹤0.01% 5524
2020
Q4
$293K Buy
24,002
+1,299
+6% +$18.1K ﹤0.01% 4888
2020
Q3
$292K Sell
22,703
-2,384
-10% -$20.6K ﹤0.01% 4735
2020
Q2
$256K Buy
25,087
+10,425
+71% +$95.9K ﹤0.01% 4769
2020
Q1
$118K Buy
14,662
+1,800
+14% +$15.6K ﹤0.01% 4980
2019
Q4
$111K Sell
12,862
-1,994
-13% -$11.2K ﹤0.01% 5248
2019
Q3
$91K Buy
14,856
+1,695
+13% +$13.7K ﹤0.01% 5362
2019
Q2
$218K Buy
13,161
+8,768
+200% +$152K ﹤0.01% 4933
2019
Q1
$73K Sell
4,393
-13
-0.3% -$187 ﹤0.01% 5230
2018
Q4
$51K Sell
4,406
-33
-0.7% -$668 ﹤0.01% 5512
2018
Q3
$178K Buy
4,439
+3,324
+298% +$94.6K ﹤0.01% 5064
2018
Q2
$32K Sell
1,115
-5,984
-84% -$133K ﹤0.01% 5716
2018
Q1
$108K Buy
7,099
+218
+3% +$5.19K ﹤0.01% 5271
2017
Q4
$225K Buy
+6,881
New +$185K ﹤0.01% 4902
2016
Q3
Sell
-125
Closed -$1K 6389
2016
Q2
$1K Hold
125
﹤0.01% 6036
2016
Q1
$3K Buy
125
+100
+400% +$2.12K ﹤0.01% 5978
2015
Q4
$1K Hold
25
﹤0.01% 6124
2015
Q3
$1K Sell
25
-175
-88% -$9.88K ﹤0.01% 6091
2015
Q2
$9K Buy
+200
New +$7.47K ﹤0.01% 5851